Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Orphazyme Receives Orphan Drug Designation To Arimoclomol For Inclusion Body Myositis From The U.S. FDA
Wednesday, November 08, 2017Orphazyme AS a Danish biotech company with a late stage orphan drug pipeline today announced that the US Food and Drug Administration FDA Office of Orphan Products Development has granted an orphan drug designation to arimoclomol for the treatment of...
Kaken Pharmaceutical and Tai Tien Pharmaceuticals Enter into a distribution Agreement for Clenafin/Jublia in Taiwan
Wednesday, November 08, 2017Kaken Pharmaceutical Co Ltd and Tai Tien Pharmaceuticals Co Ltd which is a consolidated subsidiary of Mitsubishi Tanabe Pharma Corporation head office Chuoku Osaka President and Representative Director Masayuki Mitsuka announced today that Kaken and...
TherapeuticsMD Announces Plan to Resubmit the New Drug Application for TX-004HR
Tuesday, November 07, 2017TherapeuticsMD Inc an innovative womens healthcare company today announced a regulatory update regarding the New Drug Application NDA for TXHR the Companys investigational applicatorfree estradiol vaginal softgel capsule for the treatment of moderate...
Fujifilm Expands Biopharmaceutical Contract Development and Manufacturing Business
Tuesday, November 07, 2017FUJIFILM Corporation is to invest a total of billion yen on its CDMO sites in the USA and the UK in order to accelerate the expansion of the companys business for developing and manufacturing biopharmaceuticals under contract for other parties In...
Otsuka Announces Phase 3 Results for Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Monday, November 06, 2017Otsuka Pharmaceutical Co Ltd Otsuka today announced detailed results from the Phase REPRISE trial of tolvaptan in patients with autosomal dominant polycystic kidney disease ADPKD Trial results showed that tolvaptan showed greater reduction on the...
Merck KGaA, Darmstadt, Germany Presents Late Breaking Clinical Data from Phase II Trial of Sprifermin for Osteoarthritis Disease Modification
Monday, November 06, 2017Merck KGaA Darmstadt Germany a leading science and technology company which operates its healthcare business in the US and Canada as EMD Serono today announced results of the twoyear primary analysis of FORWARD a fiveyear multicenter Phase II study o...
Merck and CDRD Announce Joint Investment in the Canadian Life Sciences Ecosystem
Saturday, November 04, 2017The Canadian scientific community gathered in Ottawa this week to engage in a national dialogue on science technology and innovation policy at the annual Canadian Science Policy Conference Just prior to the Keynote Address at this event by the Honour...
WuXi Biologics and Pall Corporation Establish Joint Continuous Bioprocess Laboratory
Friday, November 03, 2017WuXi Biologics a global leading openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing and its partner Pall Corporation the global leader of advanced filtration separation an...
Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases
Friday, November 03, 2017Boehringer Ingelheim and Dicerna Pharmaceuticals a leading developer of investigational RNA interference RNAi therapeutics today announced a research collaboration and license agreement to discover and develop novel GalXC RNAi therapeutics for the tr...
Teva Announces Completion of PARAGARD® Divestiture to CooperSurgical
Thursday, November 02, 2017Teva Pharmaceutical Industries Ltd announced it has completed the divestiture of PARAGARD intrauterine copper contraceptive to CooperSurgical in a billion cash transaction This transaction includes Tevas manufacturing facility in Buffalo NY which pr...
